Filgrastim or methionyl-granulocyte colony-stimulating factor (Met-G-CSF), is a recombinant therapeutic protein widely used to treat severe neutropenia caused by myelosuppressive drugs in patients with nonmyeloid malignancies. | Preclinical and clinical phase I studies of a new recombinant Filgrastim (BK0023) in comparison with Neupogen®